MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$21,667K
EPS
-$0.36
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
16,955
13,562
12,092*
9,591
General and administrative
6,369
6,067
5,439*
5,169
Total operating expenses
23,324
19,629
17,530
14,760
Income (loss) from operations
-23,324
-19,629
-17,530*
-14,760
Interest and investment income (expense)
1,656
1,847
1,688*
1,502
Other income (expense)
-
-
730*
-
Other income (expense), net
1,656
1,847
2,418*
1,502
Net income (loss)
-21,668
-17,782
-15,112*
-13,258
Net unrealized gain (loss) on marketable debt securities
1
-454
7
66
Other comprehensive income (loss)
1
-454
7*
66
Comprehensive income (loss)
-21,667
-18,236
-15,105
-13,192
Basic EPS
-0.36
-0.31
-0.344
-0.31
Diluted EPS
-0.36
-0.31
-0.344
-0.31
Basic Average Shares
61,006,766
57,538,833
43,965,428
42,272,104
Diluted Average Shares
61,006,766
57,538,833
43,965,428
42,272,104
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net unrealized gain
(loss) on marketable...
$1K
(108.33%↑ Y/Y)
Comprehensive income (loss)
-$21,667K
(-44.72%↓ Y/Y)
Other comprehensive
income (loss)
$1K
(108.33%↑ Y/Y)
Interest and investment
income (expense)
$1,656K
(1.85%↑ Y/Y)
Net income (loss)
-$21,668K
(-44.84%↓ Y/Y)
Other income
(expense), net
$1,656K
(1.85%↑ Y/Y)
Income (loss) from
operations
-$23,324K
(-40.62%↓ Y/Y)
Total operating
expenses
$23,324K
(40.62%↑ Y/Y)
Research and development
$16,955K
(57.43%↑ Y/Y)
General and
administrative
$6,369K
(9.51%↑ Y/Y)
Buy us a coffee
Protara Therapeutics, Inc. (TARA)
Protara Therapeutics, Inc. (TARA)